AR006810A1 - Compuestos antibacterianos de carbapenem, composiciones que contienen tales compuestos y su uso para preparar medicamentos - Google Patents
Compuestos antibacterianos de carbapenem, composiciones que contienen tales compuestos y su uso para preparar medicamentosInfo
- Publication number
- AR006810A1 AR006810A1 ARP970101648A ARP970101648A AR006810A1 AR 006810 A1 AR006810 A1 AR 006810A1 AR P970101648 A ARP970101648 A AR P970101648A AR P970101648 A ARP970101648 A AR P970101648A AR 006810 A1 AR006810 A1 AR 006810A1
- Authority
- AR
- Argentina
- Prior art keywords
- substituted
- unsubstituted
- groups
- nrarb
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
- C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
- C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
- C07D477/14—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 3
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Un compuesto antibacteriano de carbapenem que está representado por la fórmula (I) o una sal farmacéuticamente aceptable del mismo, en donde: R1 esH o metil; CO2M es un ácido carboxílico, un anión carboxilato, un grupo éster, farmacéuticamenteaceptable o un ácido carboxílico protegido por un grupoprotector; P es hidrógeno, hidroxilo, F o un hidroxilo protegido por un grupo protector de hidroxio; cada R se selecciona independientemente de -R4,-Q, H,halógeno, -CN, -NO2, -NRaRb, -ORc,-SRc , -C(O)NRaRb, C(O)ORh, -S(O)Rc, -SO2Rc, -SO2NRaRb, -NRaSO2Rh, -C(O)Ra, -OC(O)Ra, -OC(O)NRaRb, -NRaC(O)NRbRc,-NRaCO2RH,-OCO2RH, -NRaC(O)Rb, alquil-C1-6 recto o ramificado, no substituido o substituido con uno a cuatro grupos Rd, y cicloalquilC3-7 no substituidoo substituido con uno a cuatro grupos Rd. Con la salvedad que al menos está presente un R que contiene, al menos, una carga positiva; cada uno de Ra, Rby Rc, independientemente es H, R1, -alquil C1-6 de cadena recta oramificada, no substituido o substituido, desde uno hasta cuatro grupos Rd, o -cicloalquilC3-7 no substituido o substituido con uno a cuatro grupos Rd; o Ra y Rb, tomados en conjunto con cualquiera de los átomos que intervienen, es unanillosaturado de cu atro a seis miembros, opcionalmente interrumpido por uno o más de O, S, NRc, con Rc como se definió anteriormente, o -C(O)-, dichoanillo está no substituido o substituido con desde uno hasta cuatro grupos Ri; o Rb y Rc, tomadosjuntos con cualquie r átomo que intervenga son un anillosaturado de cuatro a seis miembros, opcionalmente interrumpido por uno a tres de O, S, Nra, con Ra como se definión anteriormente, o -C(O)-, dicho anilloestá no-substituaido o substituido condesde uno hasta cuat ro grupos Rb; cada Rd independientemente es halógeno, -CN, -NO2, -NReRf, -ORg, SRg, - CONReRf
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US1618496P | 1996-04-24 | 1996-04-24 | |
| GBGB9609741.5A GB9609741D0 (en) | 1996-05-10 | 1996-05-10 | Carbapenem antibacterial compounds compositions containing such componds and methods of treatment |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR006810A1 true AR006810A1 (es) | 1999-09-29 |
Family
ID=26309297
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP970101648A AR006810A1 (es) | 1996-04-24 | 1997-04-23 | Compuestos antibacterianos de carbapenem, composiciones que contienen tales compuestos y su uso para preparar medicamentos |
Country Status (31)
| Country | Link |
|---|---|
| EP (1) | EP0906313B1 (es) |
| JP (1) | JP3176068B2 (es) |
| KR (1) | KR20000010599A (es) |
| CN (1) | CN1074767C (es) |
| AR (1) | AR006810A1 (es) |
| AT (1) | ATE260915T1 (es) |
| AU (1) | AU707459B2 (es) |
| BG (1) | BG102949A (es) |
| BR (1) | BR9708864A (es) |
| CA (1) | CA2252402C (es) |
| CO (1) | CO4990968A1 (es) |
| CZ (1) | CZ340798A3 (es) |
| DE (1) | DE69727931T2 (es) |
| EA (1) | EA001296B1 (es) |
| EE (1) | EE03689B1 (es) |
| ES (1) | ES2216142T3 (es) |
| HK (1) | HK1021186A1 (es) |
| HR (1) | HRP970213A2 (es) |
| HU (1) | HUP9901778A3 (es) |
| ID (1) | ID16662A (es) |
| IL (1) | IL126480A0 (es) |
| IS (1) | IS4861A (es) |
| NO (1) | NO984949L (es) |
| NZ (1) | NZ332183A (es) |
| PE (1) | PE64298A1 (es) |
| PL (1) | PL186881B1 (es) |
| SK (1) | SK283550B6 (es) |
| TR (1) | TR199802140T2 (es) |
| TW (1) | TW539677B (es) |
| WO (1) | WO1997040048A1 (es) |
| YU (1) | YU46298A (es) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6406457B1 (en) | 1994-03-02 | 2002-06-18 | Scimed Life Systems, Inc. | Block copolymer elastomer catheter balloons |
| US7163522B1 (en) | 1994-03-02 | 2007-01-16 | Scimed Life Systems, Inc. | Block copolymer elastomer catheter balloons |
| AU728091B2 (en) * | 1997-05-13 | 2001-01-04 | Merck & Co., Inc. | Process for synthesizing carbapenem intermediates |
| US5908936A (en) * | 1997-05-13 | 1999-06-01 | Merck & Co., Inc. | Process for synthesizing carbapenem intermediates |
| JP2001520229A (ja) * | 1997-10-23 | 2001-10-30 | メルク エンド カムパニー インコーポレーテッド | カルバペネム系抗菌化合物、該化合物を含有する組成物および治療方法 |
| US6140318A (en) * | 1997-10-23 | 2000-10-31 | Merck & Co., Inc. | Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment |
| AU739799B2 (en) * | 1997-10-23 | 2001-10-18 | Merck & Co., Inc. | Carbapenem antibacterial compounds, compositions and methods of treatment |
| US6271222B1 (en) * | 1998-05-28 | 2001-08-07 | Merck & Co., Inc. | Penem antibacterial compounds, compositions and methods of treatment |
| US6489471B1 (en) * | 1998-06-17 | 2002-12-03 | Merck & Co., Inc. | Process for the synthesis of carbapenem intermediates, and compounds produced |
| CA2335497A1 (en) * | 1998-06-25 | 1999-12-29 | Merck & Co., Inc. | Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment |
| EP1089999A4 (en) * | 1998-06-25 | 2002-12-04 | Merck & Co Inc | CARBAPENEM ANTIBACTERIALS (HETEROCYCLIC) SUBSTITUTED BY METHYL |
| US7672747B2 (en) | 2000-03-30 | 2010-03-02 | Lam Research Corporation | Recipe-and-component control module and methods thereof |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0429341A3 (en) * | 1989-11-20 | 1991-11-13 | Rhone-Poulenc Sante | Heterocyclic derivatives, their preparation and pharmaceuticals containing them |
| FR2661177A1 (fr) * | 1990-04-23 | 1991-10-25 | Rhone Poulenc Sante | Derives du naphtosultame antagonistes de la serotonine, leur preparation et les medicaments les contenant. |
| US5451579A (en) * | 1994-02-15 | 1995-09-19 | Merck & Co., Inc. | 1-β-methyl-carbapenem, compositions containing same and methods of use |
-
1997
- 1997-04-21 KR KR1019980708482A patent/KR20000010599A/ko not_active Application Discontinuation
- 1997-04-21 EA EA199800949A patent/EA001296B1/ru not_active IP Right Cessation
- 1997-04-21 EE EE9800355A patent/EE03689B1/xx not_active IP Right Cessation
- 1997-04-21 CZ CZ983407A patent/CZ340798A3/cs unknown
- 1997-04-21 IL IL12648097A patent/IL126480A0/xx unknown
- 1997-04-21 CN CN97195741A patent/CN1074767C/zh not_active Expired - Fee Related
- 1997-04-21 EP EP97920438A patent/EP0906313B1/en not_active Expired - Lifetime
- 1997-04-21 ES ES97920438T patent/ES2216142T3/es not_active Expired - Lifetime
- 1997-04-21 CA CA002252402A patent/CA2252402C/en not_active Expired - Fee Related
- 1997-04-21 PL PL97329376A patent/PL186881B1/pl not_active IP Right Cessation
- 1997-04-21 SK SK1454-98A patent/SK283550B6/sk unknown
- 1997-04-21 NZ NZ332183A patent/NZ332183A/xx unknown
- 1997-04-21 HU HU9901778A patent/HUP9901778A3/hu unknown
- 1997-04-21 YU YU46298A patent/YU46298A/sh unknown
- 1997-04-21 DE DE69727931T patent/DE69727931T2/de not_active Expired - Lifetime
- 1997-04-21 AU AU24629/97A patent/AU707459B2/en not_active Ceased
- 1997-04-21 TR TR1998/02140T patent/TR199802140T2/xx unknown
- 1997-04-21 JP JP53823697A patent/JP3176068B2/ja not_active Expired - Fee Related
- 1997-04-21 AT AT97920438T patent/ATE260915T1/de not_active IP Right Cessation
- 1997-04-21 BR BR9708864A patent/BR9708864A/pt not_active IP Right Cessation
- 1997-04-21 WO PCT/US1997/006626 patent/WO1997040048A1/en not_active Application Discontinuation
- 1997-04-22 HR HR9609741.5A patent/HRP970213A2/xx not_active Application Discontinuation
- 1997-04-22 PE PE1997000306A patent/PE64298A1/es not_active Application Discontinuation
- 1997-04-23 AR ARP970101648A patent/AR006810A1/es not_active Application Discontinuation
- 1997-04-23 ID IDP971350A patent/ID16662A/id unknown
- 1997-04-23 TW TW086105293A patent/TW539677B/zh active
- 1997-04-24 CO CO97021827A patent/CO4990968A1/es unknown
-
1998
- 1998-10-06 IS IS4861A patent/IS4861A/is unknown
- 1998-10-23 NO NO984949A patent/NO984949L/no not_active Application Discontinuation
- 1998-11-23 BG BG102949A patent/BG102949A/bg unknown
-
2000
- 2000-01-10 HK HK00100158A patent/HK1021186A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR006810A1 (es) | Compuestos antibacterianos de carbapenem, composiciones que contienen tales compuestos y su uso para preparar medicamentos | |
| AR091929A1 (es) | Compuestos que son agentes moduladores de s1p y/o agentes moduladores de atx | |
| AU512448B2 (en) | The use of cyclic carbonic acid esters as solvents for poly-(b-hydroxy butric acid | |
| CO5560609A2 (es) | Oxazolidinona y/o isoxazolina como agentes antibacteriales | |
| IE782493L (en) | Phosphonoformic acid derivatives | |
| ES8604576A1 (es) | Procedimiento para preparar derivados de benzodifuranona. | |
| SE8004329L (sv) | Forfarande for framstellning av antibakteriella emnen | |
| AR007021A1 (es) | Derivados de 3-descladinosa-2,3-anhidroeritromicina, procedimientos para su preparacion, compuestos para su exclusivo uso en dichos procedimientosy procedimiento para su preparacion, una composicion farmaceutica para tratar infecciones bacterianas y el uso de estos compuestos para preparar medicamentos | |
| CO5261628A1 (es) | Compuestos | |
| SE8305917D0 (sv) | Mellanprodukter for anvendning vid framstellning av hexahydro-gamma-karbolinforeningar | |
| ES8201940A1 (es) | Un procedimiento para preparar derivados de esteres de aci- dos ciclopropanocarboxilicos | |
| GB1015787A (en) | Tris-(p-methoxyphenyl)ethylene derivatives | |
| ES2054502T3 (es) | Esteres del acido 10-(1-hidroxietil)-11-oxo-1-azatriciclo(7.2.0.0(3.8))-undec-2-en-2-carboxilico y un procedimiento para su preparacion. | |
| SE8005663L (sv) | Forfarande for framstellning av en farmaceutiskt aktiv komposition | |
| SE416543B (sv) | Sibstituerat cyklopentanderivat till anvendning som mellanprodukt vid framstellning av farmaceutiskt aktiva prostaglandinanaloger | |
| KR920021548A (ko) | 테트라사이클릭 항생제 및 이의 제조방법 | |
| SE7607300L (sv) | Tiaxantenforeningar samt forfarande for framstellning av dem | |
| NZ503880A (en) | Orally-active nipecotamide glycolamide esters for the treatment of thrombosis disorders | |
| CA1268183A (en) | INTERMEDIATES OF PHOSPHORANE USED IN THE PREPARATION OF ANTIBIOTIC PENEMS | |
| SE7408395L (es) | ||
| JPS55120575A (en) | Cis-2,3-epoxy-4-lower alkoxyphenylbutanoic acid derivative and its production | |
| JPS54160335A (en) | Preparation of alkylated hydroxybenzoic ester | |
| Bick et al. | Biogenesis of proteaceous alkaloids | |
| ES2144271T3 (es) | Sintesis de derivados de acido carboxilico. | |
| ES358926A1 (es) | Procedimiento de presentacion de productos que tienen acti-vidad antiespastica y antiulcera. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |